On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

PharmaLogic is set to acquire a majority stake in Agilera Pharma to generate the CDMO focusing on radiopharmaceutical ...

The FDA has granted approval for the injectable antibiotic, Piperacillin and Tazobactam, to be used in B Braun's drug ...

The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly ...

The Montes Claros site in Brazil is just one of many that Novo Nordisk has poured billions of dollars into as part of efforts ...

US President Donald Trump has stated that the country is set to announce “major tariffs” on pharmaceutical imports very soon.

Pharma CEOs have told EC President von der Leyen they may shift operations towards the US as trade tensions escalate.

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

With liver ailments on the rise, and obesity a key driver, understanding the treatment options available is critical.

Degrees has signed a patent licence agreement with Yale School of Medicine for tafenoquine development for babesiosis.

The EC has granted marketing authorisation for AbbVie's once-a-day treatment Rinvoq (upadacitinib) 15mg for adults with GCA.

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...